February 2025:
Loma announces Board of Directors.
We are thrilled to announce that a board of directors has been established, reflecting the growth and further development of Loma.
The board of directors of Loma comprises:
Chair Alejandra Mørk: Alejandra has over 30 years of experience in drug development, spanning early-stage development, MAAs, and life cycle management for biologics, small molecules, new delivery systems, and gene/cell therapies. Since acquiring KLIFO in 2008, she has built a successful consultancy helping biotech and pharma companies with CMC development, regulatory process and clinical development.
Board member Leif Helth Jensen: Leif has over 30 years of experience in the pharmaceutical and biotech industries, holding senior leadership roles, including CEO and several chairman positions. He co-founded several successful biotech ventures and has a strong track record in drug discovery, corporate management, and life sciences investment. He has also served on various boards and advisory committees across the healthcare sector.
Board member Stuart Collinson: Stuart’s life science industry experience includes venture capital, CEO, and board roles in public and private companies in North America and Europe. Activities have included raising capital, mergers and acquisitions, business development, and corporate and commercial strategy in North America, Europe, Brazil, and Japan.
Board member Ralf Wagner: Ralf has extensive experience as a university professor and Head of Molecular Microbiology and Virology at the University of Regensburg, renowned for his expertise in synthetic biology and the development of vaccines “from bench to clinic”. He founded and led GeneArt AG as CEO through its IPO and subsequent acquisition by Life Technologies Inc. (now part of Thermofisher Inc.) He served as Interim CEO and chairman at Lophius GmbH. He co-founded several biotech companies and actively contributes as a board member and business coach, driving the translation of academic research into commercial success.